National Recognition for Innovation
The Office of the National Leading Group for the Administration of High-Tech Enterprise Certification under China's Ministry of Science and Technology has released its announcement regarding the first batch of high-tech enterprises certified in Shenzhen in 2021. Medgen Life Science has been officially certified as a National High-Tech Enterprise.
This certification recognizes and affirms Medgen Life Science's innovation capabilities, R&D strength, and technology commercialization ability, and serves as an auspicious milestone for the company's 2022 journey. The Medgen team remains firmly committed to its founding mission of "from medicine, for medicine," dedicated to developing and producing more technologically advanced medical products.
About the National High-Tech Enterprise Certification
The "National High-Tech Enterprise" certification is a qualification established by the Chinese government to support key enterprise development and represents one of the most prestigious honors for technology innovation companies in China. Being recognized as a high-tech enterprise reflects a company's comprehensive scientific research capabilities and market potential.
The certification is guided, managed, and supervised by the Ministry of Science and Technology, the Ministry of Finance, and the State Taxation Administration. It imposes strict requirements on an enterprise's core independent intellectual property, technology commercialization capability, R&D organizational management, and growth metrics.
Significance of the Certification
Medgen Life Science's successful certification as a National High-Tech Enterprise will further enhance the company's social and brand recognition. The enterprise will also benefit from a series of preferential policies and government special funding support, providing valuable assistance for talent recruitment, brand certification, and corporate innovation.
About Medgen Life Science
Medgen Life Science (Shenzhen) Co., Ltd. was established in late 2017 in Shenzhen, China's leading innovation hub. Located in the Pingshan District, the company operates over 10,000 square meters of office space and Class 10,000 clean room manufacturing facilities. Guided by its mission of "from medicine, for medicine," the company pursues pragmatic, dedicated development. Its business encompasses original R&D and commercialization of products in orthopedics, sports medicine, and anesthesia, as well as overseas biomedical equity investment and strategic partnerships.
At the time of certification, the company had accumulated 2 medical device registration certificates and a total of 17 intellectual property rights including invention patents, utility model patents, software copyrights, and integrated circuit layout designs.
Looking ahead, Medgen Life Science will use the "National High-Tech Enterprise" certification as a springboard for a new chapter of innovative development.